Email ID
Password
Generics - Products
JOB OF THE WEEK Promote your vacancy here
The plenary session at the Drug Information Association’s Euromeeting in Monaco this week took the curious form of an enforced debate on pharmaceutical R&D productivity between representatives from the industry and regulatory authorities. The motion ...
Establishments that produce substandard or counterfeit antimalarials will find it harder to sell their products to developing countries after the World Health Organization published new guidelines this week spelling out how to buy quality-made ...
India has constituted an expert group to examine the definitions of spurious, adulterated and misbranded drugs in the Drugs and Cosmetic Act and recommend changes to these in the context of "present trade practices followed nationally and ...
Venus Pharma, the German subsidiary of India's Venus Remedies, has received approval to market meropenem, a carbapenem injection, in Portugal. Meropenem, an ultra broad spectrum antibiotic, was originally developed by Sumitomo Pharmaceuticals and ...
The Russian government has introduced mandatory state registration of maximum prices and trade mark-ups for medicines on the health ministry's list of vital and essential medicines. These prices are to be kept for one year. Medicines whose prices ...
 
Advocates of microdosing, a technique that involves testing very small doses of products in humans, think it will improve the efficiency of drug development by flagging at an early stage those ...
The Haiti earthquake has led to a flurry of drug donations. As new World Health Organization guidelines come out this year, Scrip's Elizabeth Sukkar examines the problem of inappropriate drug ...
The Innovative Medicines Initiative (IMI) is a public-private partnership which aims to bolster Europe's competitive edge in pharmaceutical research and improve the mechanisms for bringing new ...
 
Jeff George took over as head of Sandoz, Novartis's generics business, in late 2008. With a big push in emerging markets, a leadership position in biosimilars and an expanded focus on injectables, he ...
Many pharmaceutical and biotech companies devote themselves to the discovery and development of novel drugs for unmet medical needs. However, with R&D costs and regulatory hurdles multiplying, and ...
After years of anti-obesity disappointments, Orexigen's Contrave, Vivus's Qnexa and Arena's lorcaserin stand on the verge of being filed with the US FDA. Professor Michael Cowley, inventor of ...
 
On July 8th, 2009, the European Commission reported on its 18-month inquiry into competition in the pharmaceuticals sector. Bill Batchelor of Baker & McKenzie 's Brussels antitrust practice ...
 
COMPANY/ORGANISATION
CONDITION
GEOGRAPHY
DRUG
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36